Annual Accounts Receivable
$2.17 M
-$1.25 M-36.52%
December 31, 2024
Summary
- As of March 12, 2025, DNLI annual accounts receivable is $2.17 million, with the most recent change of -$1.25 million (-36.52%) on December 31, 2024.
- DNLI annual accounts receivable is now -76.61% below its all-time high of $9.28 million, reached on December 31, 2022.
Performance
DNLI Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$2.17 M
NaN%
December 31, 2024
Summary
- As of March 12, 2025, DNLI quarterly accounts receivable is $2.17 million
- Over the past year, DNLI quarterly accounts receivable has stayed the same.
- DNLI quarterly accounts receivable is now -85.73% below its all-time high of $15.22 million, reached on June 30, 2021.
Performance
DNLI Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
DNLI Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -36.5% | 0.0% |
| 3 y3 years | - | -76.6% |
| 5 y5 years | - | -76.6% |
DNLI Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -76.6% | at low | -76.6% | at low |
| 5 y | 5-year | -76.6% | at low | -85.7% | at low |
| alltime | all time | -76.6% | -100.0% | -85.7% | -100.0% |
Denali Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $2.17 M(-36.5%) | $2.17 M(-36.5%) |
| Dec 2023 | $3.42 M(-63.2%) | $3.42 M(-63.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $9.28 M(>+9900.0%) | $9.28 M(-39.0%) |
| Jun 2021 | - | $15.22 M(>+9900.0%) |
| Dec 2017 | $0.00 | $0.00 |
FAQ
- What is Denali Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for Denali Therapeutics?
- What is Denali Therapeutics annual accounts receivable year-on-year change?
- What is Denali Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Denali Therapeutics?
- What is Denali Therapeutics quarterly accounts receivable year-on-year change?
What is Denali Therapeutics annual accounts receivable?
The current annual accounts receivable of DNLI is $2.17 M
What is the all time high annual accounts receivable for Denali Therapeutics?
Denali Therapeutics all-time high annual accounts receivable is $9.28 M
What is Denali Therapeutics annual accounts receivable year-on-year change?
Over the past year, DNLI annual accounts receivable has changed by -$1.25 M (-36.52%)
What is Denali Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of DNLI is $2.17 M
What is the all time high quarterly accounts receivable for Denali Therapeutics?
Denali Therapeutics all-time high quarterly accounts receivable is $15.22 M
What is Denali Therapeutics quarterly accounts receivable year-on-year change?
Over the past year, DNLI quarterly accounts receivable has changed by $0.00 (0.00%)